Showing results (1081-1090 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|September 26, 2014
Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agentsNicholas C L Wong, Phyllis F Y Cheung, Chi Wai Yip, et al.
Molecular Cancer Therapeutics|October 17, 2014
Marine sponge Cribrochalina vasculum compounds activate intrinsic apoptotic signaling and inhibit growth factor signaling cascades in non-small cell lung carcinomaAna Zovko, Kristina Viktorsson, Petra Hååg, et al.
Molecular Cancer Therapeutics|October 17, 2014
Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancerBella S Guerrouahen, Jennifer Pasquier, Nadine Abu Kaoud, et al.
Molecular Cancer Therapeutics|August 2, 2014
Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanomaRaghavendra Gowda, SubbaRao V Madhunapantula, Arati Sharma, et al.
Molecular Cancer Therapeutics|August 2, 2014
Calpain-mediated integrin deregulation as a novel mode of action for the anticancer gallium compound KP46Ute Jungwirth, Johannes Gojo, Theresa Tuder, et al.
Molecular Cancer Therapeutics|July 17, 2014
Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanineSean P Arlauckas, Anatoliy V Popov, Edward J Delikatny
Molecular Cancer Therapeutics|July 24, 2014
Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastomaAnaïs Balbous, Brigitte Renoux, Ulrich Cortes, et al.
Molecular Cancer Therapeutics|November 5, 2013
Increasing the antitumor effect of an EpCAM-targeting fusion toxin by facile click PEGylationManuel Simon, Nikolas Stefan, Lubor Borsig, et al.
Molecular Cancer Therapeutics|November 7, 2013
OATP1A/1B transporters affect irinotecan and SN-38 pharmacokinetics and carboxylesterase expression in knockout and humanized transgenic miceDilek Iusuf, Marion Ludwig, Ahmed Elbatsh, et al.
Molecular Cancer Therapeutics|November 7, 2013
Reversible action of diaminothiazoles in cancer cells is implicated by the induction of a fast conformational change of tubulin and suppression of microtubule dynamicsNisha E Thomas, Reshma Thamkachy, Krishnankutty C Sivakumar, et al.
Pageof 599